Find clinical trials for Prostate Cancer in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Hanyang, Seoul, KOR:
8 weeks (±2 weeks) to patients with metastatic castration resistant prostate cancer (mCRPC) in order to assess the safety and effic...
Phase 2
Seoul, Korea, Republic of
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Seoul, Korea, Republic of and 52 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Seoul, Korea, Republic of and 131 other locations
A phase 3, multi-center, single-group, open-label study to evaluate the efficacy and safety of DKF-MA102 in patients with prostate cancer...
Phase 3
Seoul, Korea, Republic of
The main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or sec...
Phase 3
Hong Kong, Hong Kong and 7 other locations
second-line androgen receptor (AR) directed therapy with enzalutamide or docetaxel (chemotherapy) for treating metastatic castration-resistant prostate...
Phase 3
Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of and 87 other locations
This study will explore whether a combination of the investigational drug PF-06821497 and enzalutamide will work better than taking enzalutamide alon...
Phase 3
Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of and 56 other locations
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of and 112 other locations
examination to determine the presence of recurrent or metastatic prostate cancer in patients whose recurrent or metastatic lesions ...
Phase 3
Seoul, Korea, Republic of and 5 other locations
compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate...
Phase 3
Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of and 231 other locations
Clinical trials
Research sites
Resources
Legal